Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
980.8 DKK | -0.77% | +4.89% | +40.67% |
Jun. 10 | Dsm-firmenich sees boost as weight-loss drugs spur healthier choices | RE |
Jun. 10 | Argus Research Raises Novo Nordisk Price Target to $160 From $125, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.67% | 631B | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+16.85% | 249B | |
-1.80% | 216B | |
+11.08% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk Plans First Bond Sale in Two Years